Please login to the form below

Not currently logged in
Email:
Password:

EU Commission launches pharmaceutical consultation

The EU Commission has launched a consultation on the future of pharmaceuticals for human use in the EU, as a part of its programme to improve the regulatory, non-regulatory and research, technology and development framework for drugs in the region.

The EU Commission has launched a consultation on the future of pharmaceuticals for human use in the EU, as a part of its programme to improve the regulatory, non-regulatory and research, technology and development framework for drugs in the region.

The commission has identified three major challenges impacting the pharmaceutical sector in Europe: the globalisation of the sector; the smooth functioning of the internal market; and advances in science and technology.

The commission said that due to structural factors, such as labour costs, much worldwide R&D investment in the field is slowly moving to the US and Asia on a global level.

For the internal market, the commission highlighted obstacles to the free movement of medicines, especially the safety of medicines. Recent analysis demonstrated the existence of multiple and sometimes inefficient requirements as regards pharmacovigilance in the EU. The commissioned advised that the challenge was to strengthen and rationalise drug safety monitoring, while avoiding unnecessary requirements that would delay patients' access to treatments.

The increasing involvement of patients in monitoring their own health was a developing trend in the industry and the Commission said that patients needed better access to quality information.

The commission lastly identified advances in regenerative medicine, personalised treatments and the development of nanomedicines as trends all affecting the way medicines are tested and eventually prescribed.

Key questions asked by the commission concern other challenges to the industry, such as what measure could be implemented to ensure the safety of medicines supplied to the EU, how to improve the EU's international competitiveness and how the EU regulatory framework can be applied to emerging technologies.

6th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics